recombinant hepatitis B vaccine (Hansenula polymorpha)
/ Sinovac
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 29, 2021
Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg)
(clinicaltrials.gov)
- P1; N=144; Completed; Sponsor: Sinovac Biotech Co., Ltd; Recruiting ➔ Completed
Trial completion • Hepatitis B • Hepatology • Infectious Disease • Inflammation
1 to 1
Of
1
Go to page
1